000 02352nam a22005175i 4500
001 60134
005 20200226102341.0
007 cr nn 008mamaa
008 161114s2017 gw | s |||| 0|eng d
020 _a9783319432960
_9978-3-319-43296-0
024 7 _a10.1007/978-3-319-43296-0
_2doi
035 _a(DE-He213)978-3-319-43296-0
050 4 _aRC648-665.2
072 7 _aMJGD
_2bicssc
072 7 _aMED027000
_2bisacsh
072 7 _aHEA039050
_2bisacsh
082 0 4 _a616.462
_223
082 0 4 _a616.46
_223
100 1 _aFisher, Miles.
_eauthor.
245 1 0 _aEssentials of SGLT2 Inhibitors in Diabetes
_h[electronic resource] /
_cby Miles Fisher, Gerard McKay.
264 1 _aCham :
_bSpringer International Publishing :
_bImprint: Adis,
_c2017.
300 _aXI, 68 p. 13 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aOverview of Type 2 Diabetes -- SGLT2 Inhibitors for Treating Diabetes -- Guidelines for the Treatment of Type 2 Diabetes Mellitus -- Using SGLT2 Inhibitors in Special Populations.
520 _aWritten by experts in the field, this clinical handbook explores the novel SGLT2 drug class for the treatment of diabetes. This book includes evidence-based guidelines, major clinical trials, and a discussion of treatment options currently available, as well as those currently in development. Essentials of SGLT2 Inhibitors is an ideal educational resource for busy medical professionals who need to stay up-to-date with diabetes treatment advances in order to provide the best possible clinical care for their patients.
650 0 _aMedicine.
650 0 _aGeneral practice (Medicine).
650 0 _aDiabetes.
650 0 _aEndocrinology.
650 0 _aPrimary care (Medicine).
650 1 4 _aMedicine & Public Health.
650 2 4 _aDiabetes.
650 2 4 _aPrimary Care Medicine.
650 2 4 _aGeneral Practice / Family Medicine.
650 2 4 _aEndocrinology.
700 1 _aMcKay, Gerard.
_eauthor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783319432946
856 4 0 _uhttp://dx.doi.org/10.1007/978-3-319-43296-0
912 _aZDB-2-SME
999 _c2394
_d2394